Lisa Jennings, PhD, Founder/CEO of CirQuest Labs, addresses the first meeting of the Academic Alliance, Memphis Chapter. The meeting was hosted by Life Science Tennessee and supported by St. Jude Children’s Research Hospital, University of Memphis, University of Tennessee Health … Continue reading
Press Release MEMPHIS T.N., (October 2, 2013) – CirQuest Labs is expanding predictive laboratory analytic capabilities to meet the growing needs of clients seeking to determine how persons’ genetic differences may affect their response to drug therapy. The breakthrough analytical … Continue reading
Dr. Lisa Jennings will be attending the Outsourcing In Clinical Trials – Southeast conference in Durham, NC May 14 – 16, 2012.
On March 24, 2012, Dr. Lisa Jennings delivered an oral presentation at the American College of Cardiology’s 2012 Scientific Sessions in Chicago. Dr. Jennings’ talk was entitled, “Pharmacodynamics of Vorapaxar, a Platelet PAR-1 Antagonist, and Its Interaction with P2y12 Receptor … Continue reading
CirQuest Labs, LLC will be attending the upcoming ODT Forum in Memphis Tennessee on May 3, 2012. As an industry leader in life science services, CirQuest will promote validation testing capabilities and will network with industry professionals.The focus of this … Continue reading
Dr. Lisa Jennings understands that creating new drugs is important. She also understands that how the drug interacts with the body is even more important. Jennings is the founder of CirQuest Labs, a three-year-old contract research organization (CRO) that provides … Continue reading
After initial success performing research and drug trials for large pharmaceutical manufacturers, a young Memphis biotech firm is ready to swing for the fences. CirQuest Labs is preparing to begin research and de- velopment into its own anti-clotting drugs. CirQuest … Continue reading
Ask Dr. Lisa Jennings, director of vascular biology at the University of Tennessee Health Science Center and founder of CirQuest Labs, about the role of academic science in the creation of future jobs and her answer is clear: “I’m a … Continue reading